Articles
HCPCS Modifier LU
Modifier LU describes a fractionated payment of Chimeric Antigen Receptor T-cell Therapy with an implementation date of January 31, 2023.
MLN Matters: MM12928
For additional information, please refer to cms.gov for additional i...
HCPCS modifier JZ
Modifier JZ is used to describe that no amount of the drug was discarded. It is utilized when the drug administered is in a single-dose container.
CMS Billing Guidelines
For additional information, please refer to cms.gov ...
HCPCS Modifier JB
Modifier JB describes that the medication was administered subcutaneously. It is utilized when there are multiple modes of administration of the drug you are billing.
CMS Billing Manual - Modifier JB on page 50
For additional info...
HCPCS Modifier JA
Modifier JA describes that the medication was administered intravenously. It is utilized when there are multiple modes of administration of the drug you are billing.
CMS Billing Manual - Modifier JA on page 50
For additional i...